Needham Reiterates Buy on Absci, Maintains $11 Price Target
9/23/2026
Impact: 75
Healthcare
Needham analyst Gil Blum has reiterated a Buy rating on Absci (NASDAQ: ABSI) and has maintained a price target of $11 for the stock.
AI summary, not financial advice
Share: